These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 648939)

  • 21. Controlled comparison of cimetidine and carbenoxolone sodium in gastric ulcer.
    La Brooy SJ; Taylor RH; Hunt RH; Golding PL; Laidlaw JM; Chapman RG; Pounder RE; Vincent SH; Colin-Jones DG; Milton-Thompson GJ; Misiewicz JJ
    Br Med J; 1979 May; 1(6174):1308-9. PubMed ID: 376054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbenoxolone interactions in man--preliminary report.
    Thornton PC; Papouchado M; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():35-9. PubMed ID: 6937939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of carbenoxolone sodium on the plasma 11 hydroxycorticoid levels in chronic gastric ulceration.
    Gollan JL; Hecker R; Mackinnon AM
    Aust N Z J Med; 1975 Jun; 5(3):231-4. PubMed ID: 1057935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans.
    Celinski K; Konturek PC; Konturek SJ; Slomka M; Cichoz-Lach H; Brzozowski T; Bielanski W
    J Physiol Pharmacol; 2011 Oct; 62(5):521-6. PubMed ID: 22204799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symposium on peptic ulcer disease. 1. Medical treatment of peptic ulcer.
    Jeejeebhoy KN
    Can J Surg; 1978 Jan; 21(1):17-8. PubMed ID: 579607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pirenzepine (LS 519) in severe duodenal ulcer and in gastric ulcer. A double-blind clinical trial.
    Oselladore D; Chierichetti SM; Norberto L; Vibelli C
    Scand J Gastroenterol Suppl; 1979; 57():33-9. PubMed ID: 396655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind trial of carbenoxolone sodium capsules in duodenal ulcer therapy, based on endoscopic diagnosis and follow-up.
    Brown P; Salmon PR; Thien-Htut ; Read AE
    Br Med J; 1972 Sep; 3(5828):661-4. PubMed ID: 4568356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trial of a new carbenoxolone analogue (BX24), zinc sulphate, and vitamin A in the treatment of gastric ulcer.
    Fraser PM; Doll R; Langman MJ; Misiewicz JJ; Shawdon HH
    Gut; 1972 Jun; 13(6):459-63. PubMed ID: 4557308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbenoxolone patients with gastric ulcers. A double-blind trial.
    Schwamberger K; Reissigl H
    Scand J Gastroenterol Suppl; 1980; 65():59-62. PubMed ID: 7010529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrolyte status in duogastrone--treated duodenal ulcer patients.
    Odutola TA; Oladapo JM; Falaiye JM
    Niger Med J; 1978 Jul; 8(4):337-9. PubMed ID: 726667
    [No Abstract]   [Full Text] [Related]  

  • 31. Carbenoxolone (duogastrone) and cimetidine in the treatment of duodenal ulcer--a therapeutic trial.
    Cook PJ; Vincent-Brown A; Lewis SI; Perks S; Jewell DP; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():93-101. PubMed ID: 7010531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbenoxolone sodium for gastric ulcer.
    Med Lett Drugs Ther; 1975 Aug; 17(16):67-8. PubMed ID: 1097883
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytoprotective therapy of gastric ulcers: a controlled clinical evaluation of triletide versus carbenoxolone.
    Campisi D; Cataldo MG; Paterna S; Bivona A; Barbarino C
    Pharmatherapeutica; 1985; 4(3 Spec No):166-70. PubMed ID: 3903785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Undesirable effects of Biogastrone in the treatment of peptic ulcer (author's transl)].
    Zelenková J; Toman R; Svoboda M; Svihovec J
    Cesk Gastroenterol Vyz; 1976 Oct; 30(7):427-33. PubMed ID: 797473
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes in the plasma clearance and protein binding of carbenoxolone with age, and their possible relationship with adverse drug effects.
    Hayes MJ; Sprackling M; Langman MJ
    Gut; 1977 Dec; 18(12):1054-8. PubMed ID: 606633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Undesirable effects of carbenoxolone treatment in patients with ulcus ventriculi].
    Henrichsen L; Pedersen H; Jensen KB; Wulff HR
    Ugeskr Laeger; 1976 Dec; 138(51):3265-7. PubMed ID: 793123
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of the combinations atropine + cyproheptadine and atropine + carbenoxolone in duodenal ulcer therapy.
    Tárnok F; Deák G; Jávor T; Mózsik G; Nagy L; Patty I
    Int J Tissue React; 1983; 5(3):315-21. PubMed ID: 6654627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sucralfate effervescent tablet: treatment of peptic ulcer disease and change in serum aluminium concentration.
    Schütze K; Hentschel E; Happonen P; Akkila J
    Hepatogastroenterology; 1995 Jul; 42(3):240-5. PubMed ID: 7590572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric and duodenal ulcer healing under placebo treatment.
    Scheurer U; Witzel L; Halter F; Keller HM; Huber R; Galeazzi R
    Gastroenterology; 1977 May; 72(5 Pt 1):838-41. PubMed ID: 849813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tolerance of carbenoxolone sodium in elderly patients (author's transl)].
    Hagenmüller F; Wurbs D; Classen M
    Leber Magen Darm; 1977 Dec; 7(6):385-8. PubMed ID: 593029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.